Gastroenteropancreatic neuroendocrine tumour arising in Meckel’s diverticulum coexisting with colon adenocarcinoma

Saved in:
Bibliographic Details
Title: Gastroenteropancreatic neuroendocrine tumour arising in Meckel’s diverticulum coexisting with colon adenocarcinoma
Authors: Katalinić, Darko, Šantek, Fedor, Juretić, Antonio, Škegro, Dinko, Pleština, Stjepko
Source: World J Surg Oncol
Publisher Information: Springer Science and Business Media LLC, 2014.
Publication Year: 2014
Subject Terms: Gastroenteropancreatic neuroendocrine tumour, Male, Meckel Diverticulum/surgery, Colon adenocarcinoma, Meckel's diverticulum, Intestinal Neoplasms/surgery, Meckel Diverticulum/pathology, Adenocarcinoma/surgery, Case Report, Neoplasms, Multiple Primary/surgery, Stomach Neoplasms/secondary, Adenocarcinoma, Intestinal Neoplasms/secondary, Pancreatic Neoplasms/secondary, Neoplasms, Multiple Primary, 03 medical and health sciences, 0302 clinical medicine, Stomach Neoplasms, Adenocarcinoma/secondary, Pancreatic Neoplasms/surgery, Intestinal Neoplasms, Neuroendocrine Tumors/secondary, Humans, Neoplasms, Multiple Primary/pathology, Neuroendocrine Tumors/surgery, Neoplasm Staging, Colonic Neoplasms/pathology, Colonic Neoplasms/surgery, Middle Aged, Prognosis, 3. Good health, Meckel Diverticulum, Pancreatic Neoplasms, Stomach Neoplasms/surgery, Neuroendocrine Tumors, Oncology, Colonic Neoplasms, Surgery
Description: Although colon cancer is the third most common cause of cancer-related death worldwide, the prevalence of gastroenteropancreatic neuroendocrine tumours (GEP-NETs) remains rare. To date, very few cases of GEP-NETs within Meckel's diverticulum and synchronous colorectal cancer have been reported. Although the coexistence of these two tumour types is uncommon, it is important to be aware of their disease patterns. We present a rare case of a patient with an intestinal GEP-NET arising in Meckel's diverticulum coexisting with metastatic colon adenocarcinoma, and we discuss the clinical manifestations and the diagnostic procedures and treatment modalities used. This case report underlines the importance of being aware of this particular coexistence, as well as the unlikely metastatic spread of GEP-NETs and the importance of a multidisciplinary approach to cancer treatment. Finally, individualizing the treatment according to the stages of the primaries will result in durable cancer control, particularly in synchronous double malignancy.
Document Type: Article
Other literature type
File Description: application/pdf
Language: English
ISSN: 1477-7819
DOI: 10.1186/1477-7819-12-358
Access URL: https://wjso.biomedcentral.com/track/pdf/10.1186/1477-7819-12-358
https://pubmed.ncbi.nlm.nih.gov/25427657
https://www.ncbi.nlm.nih.gov/pubmed/25427657
https://link.springer.com/content/pdf/10.1186%2F1477-7819-12-358.pdf
https://wjso.biomedcentral.com/articles/10.1186/1477-7819-12-358
https://link.springer.com/article/10.1186/1477-7819-12-358/fulltext.html
http://europepmc.org/articles/PMC4258279
https://link.springer.com/article/10.1186/1477-7819-12-358
http://doi.org/10.1186/1477-7819-12-358
Rights: CC BY
URL: http://rightsstatements.org/vocab/InC/1.0/
Accession Number: edsair.doi.dedup.....73b8374a0e7f9817da1fc9bca050ee9c
Database: OpenAIRE
Description
Abstract:Although colon cancer is the third most common cause of cancer-related death worldwide, the prevalence of gastroenteropancreatic neuroendocrine tumours (GEP-NETs) remains rare. To date, very few cases of GEP-NETs within Meckel's diverticulum and synchronous colorectal cancer have been reported. Although the coexistence of these two tumour types is uncommon, it is important to be aware of their disease patterns. We present a rare case of a patient with an intestinal GEP-NET arising in Meckel's diverticulum coexisting with metastatic colon adenocarcinoma, and we discuss the clinical manifestations and the diagnostic procedures and treatment modalities used. This case report underlines the importance of being aware of this particular coexistence, as well as the unlikely metastatic spread of GEP-NETs and the importance of a multidisciplinary approach to cancer treatment. Finally, individualizing the treatment according to the stages of the primaries will result in durable cancer control, particularly in synchronous double malignancy.
ISSN:14777819
DOI:10.1186/1477-7819-12-358